Can you present the challenges of the AROME session?
Yazid BELKACEMI
Oncologist-Radiotherapist, Créteil, France
Innovations in breast metastatic cancer
Frédérique PENAULT LLORCA Pathologist, Clermont Ferrand, France
What are the main biomarkers in the field of breast cancer? How to use them as predictors?
Simon NAYLER
pathologist, Johanesburgh South Africa
What’s the prognostic value of PET scan imaging as a predictive tool for ER + breast cancer patients?
Willy Vangu
nuclear medicine, Johannesburg, South Africa
Preoperative assessment with FDG Pet CT scan
Eric ZERBIB